244 related articles for article (PubMed ID: 25837178)
1. Prevalence of vitiligo and associated comorbidities in Korea.
Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH
Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea.
Kang H; Lee S
Clin Exp Dermatol; 2023 Apr; 48(5):484-489. PubMed ID: 36656897
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities associated with vitiligo: a ten-year retrospective study.
Sheth VM; Guo Y; Qureshi AA
Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
[TBL] [Abstract][Full Text] [Related]
6. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea.
Bae JM; Lee JH; Yun JS; Han B; Han TY
J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities in vitiligo: comprehensive review.
Dahir AM; Thomsen SF
Int J Dermatol; 2018 Oct; 57(10):1157-1164. PubMed ID: 29808541
[TBL] [Abstract][Full Text] [Related]
8. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
[TBL] [Abstract][Full Text] [Related]
9. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study.
Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L
Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients.
Elbuluk N; Ezzedine K
Dermatol Clin; 2017 Apr; 35(2):117-128. PubMed ID: 28317521
[TBL] [Abstract][Full Text] [Related]
11. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study.
Choi CW; Eun SH; Choi KH; Bae JM
J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282
[TBL] [Abstract][Full Text] [Related]
13. A Nationwide, Population-based Cohort Study on Potential Autoimmune Association of Ménière Disease to Atopy and Vitiligo.
Hahn HJ; Kwak SG; Kim DK; Kim JY
Sci Rep; 2019 Mar; 9(1):4406. PubMed ID: 30867466
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study.
Chu SY; Chen YJ; Tseng WC; Lin MW; Chen TJ; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
J Am Acad Dermatol; 2011 Nov; 65(5):949-56. PubMed ID: 21616562
[TBL] [Abstract][Full Text] [Related]
15. Vitiligo and associated autoimmune disease: retrospective review of 300 patients.
Sawicki J; Siddha S; Rosen C
J Cutan Med Surg; 2012; 16(4):261-6. PubMed ID: 22784519
[TBL] [Abstract][Full Text] [Related]
16. Associations of chronic urticaria with atopic and autoimmune comorbidities: a nationwide population-based study.
Chiu HY; Muo CH; Sung FC
Int J Dermatol; 2018 Jul; 57(7):822-829. PubMed ID: 29663342
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
Kim M; Choi KH; Hwang SW; Lee YB; Park HJ; Bae JM
J Am Acad Dermatol; 2017 Jan; 76(1):40-48. PubMed ID: 27793451
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis.
Lee JH; Ju HJ; Seo JM; Almurayshid A; Kim GM; Ezzedine K; Bae JM
J Invest Dermatol; 2023 May; 143(5):777-789.e6. PubMed ID: 36574529
[TBL] [Abstract][Full Text] [Related]
19. The Epidemiology of Myasthenia Gravis in Korea.
Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
[TBL] [Abstract][Full Text] [Related]
20. Effects of age of onset on disease characteristics in non-segmental vitiligo.
Solak B; Dikicier BS; Cosansu NC; Erdem T
Int J Dermatol; 2017 Mar; 56(3):341-345. PubMed ID: 28054375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
